An evaluation of neonatal abstinence treatment modalities.
D002492:Central Nervous System Depressants; D003975:Diazepam / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000139:chemically induced* / Q000188:drug therapy; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D009892:Opium / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D011379:Prognosis; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D019966:Substance-Related Disorders / Q000534:rehabilitation*
D002492:Central Nervous System Depressants; D009892:Opium; C017652:paregoric; D003975:Diazepam; D010634:Phenobarbital